We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

AstraZeneca Loses Battle Against Generic Plendil At Federal Circuit

Law360 (October 4, 2004, 12:00 AM EDT) -- A U.S. appeals court has ruled that U.K.-Swedish drug maker AstraZeneca can't prevent U.S.-based Mutual Pharmaceutical Co. from selling a generic form of hypertension drug Plendil.

The U.S. Court of Appeals...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.